Ann-christin Brorsson
Linkoeping, E 58183, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
PFAS Compounds Display Distinct Toxicological Effects in Drosophila melanogaster, Reflected by Reduced Viability and Impaired Neuronal Function.
Journal: Biomolecules
Published: February 24, 2026
Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer's disease.
Journal: PloS one
Published: November 18, 2024
A Novel Drosophila Model of Alzheimer's Disease to Study Aβ Proteotoxicity in the Digestive Tract.
Journal: International journal of molecular sciences
Published: December 05, 2023
The Luminescent Conjugated Oligothiophene h-FTAA Attenuates the Toxicity of Different Aβ Species.
Journal: Biochemistry
Published: September 01, 2021
Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster.
Journal: International journal of molecular sciences
Published: August 27, 2021
Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.
Journal: PloS one
Published: September 17, 2019
AβPP processing results in greater toxicity per amount of Aβ1-42 than individually expressed and secreted Aβ1-42 in Drosophila melanogaster.
Journal: Biology open
Published: July 09, 2016
Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster.
Journal: PloS one
Published: February 29, 2016
The Luminescent Oligothiophene p-FTAA Converts Toxic Aβ1-42 Species into Nontoxic Amyloid Fibers with Altered Properties.
Journal: The Journal of biological chemistry
Published: October 02, 2015
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease.
Journal: Neurobiology of disease
Published: June 14, 2015
Last Updated: 09/26/2026